Why academic partnerships matter
Academic collaborators bring:
- Scientific credibility, peer reviewed publications require academic coauthors
- IRB access, academic institutions can provide IRB coverage for registry research
- Technical resources, biostatisticians, bioinformaticians, data scientists
- Funding access, NIH grants, foundation grants, and clinical trial networks
- Clinical expertise, disease specialists, rare disease centers of excellence
Structuring the relationship
Data access agreements
Academic researchers accessing your registry need a signed Data Use Agreement covering:
- Permitted analyses and publications
- Prohibition on reidentification
- Data security requirements
- Publication notification and co-authorship expectations
- Data return and destruction upon project completion
IRB coordination
Define who holds IRB coverage for registry-linked research:
- Your central IRB covers the registry; academic collaborators add a linked study under their own IRB
- Academic institution provides a master IRB agreement covering all affiliated analyses
- Consider using a single central IRB (CIRB or NCI CIRB) for multisite academic networks
Authorship policy
Establish your authorship policy before the first paper:
- Registry team members are coauthors on all publications using registry data
- A participant coauthor is included on all publications (identify and support interested participants)
- Acknowledge registry participants in every paper
- First and last authorship for key papers goes to whom?
Funding considerations
NIH grants
Many registries are supported by NIH funding:
- R01: Standard research grant; advocacy organizations can be co-investigators with an academic lead PI
- U01/U34: Cooperative agreements; common for multisite registry networks
- PAR funding opportunities: NIH periodically issues targeted PARs for rare disease registries
Key resource: NIH Research Portfolio Online Reporting Tools (RePORTER)
PCORI
PCORI funds patient-centered outcomes research with a strong emphasis on participant engagement. Advocacy organizations as principal investigators are explicitly encouraged.
Foundation and advocacy funding
Many disease foundations provide seed funding for registry development. Even modest funding ($50K, $250K) can launch a registry that then attracts larger academic or industry support.
Building a productive collaboration
- Define deliverables and timelines in writing at the start
- Hold regular (monthly or quarterly) working group calls
- Share data access promptly once agreements are in place
- Be explicit about publication timelines, academic timelines can be very slow
- Provide administrative support for grant applications that use your registry as a resource
Key resources
- NIH Office of Rare Diseases Research
- PCORI
- CTSA Hub Network, Academic clinical research network
- Rare Disease Clinical Research Network (RDCRN)